These data suggest that 9‐ING‐41 effectively downregulates GSK‐3β expression and activity in the hippocampus with a limited effect on glucose and lipid metabolism in the hippocampus of ApoE4‐T2DM mice. The gene discussed is GSK3B; the disease is type 2 diabetes mellitus.